Literature DB >> 25295427

Long-term outcome of obsessive-compulsive disorder in adults: a meta-analysis.

Eesha Sharma1, Kandavel Thennarasu, Y C Janardhan Reddy.   

Abstract

OBJECTIVE: To study the long-term rate and predictors of remission in adults with obsessive-compulsive disorder (OCD), using meta-analysis. DATA SOURCES: The MEDLINE database was searched to May 2013 using the search terms obsessive-compulsive disorder, prospective, outcome study, clinical course, remission, prognosis, follow-up, and long-term and limits for language (English), species (humans), and age (adults). This was supplemented by manual bibliographic cross-referencing. STUDY SELECTION: English-language studies from peer-reviewed journals on adults with DSM-III-R, DSM-IV, DSM-IV-TR, ICD-9, or ICD-10 diagnosis of OCD followed up for ≥ 1 year and treated with serotonin reuptake inhibitors and/or cognitive-behavioral therapy that reported rate of remission (Yale-Brown Obsessive Compulsive Scale [YBOCS] score < 16 at longest follow-up) were included. DATA EXTRACTION: Data were gathered as numbers/means/percentages/categories on sample size, study design, follow-up duration, age at assessment, illness duration, age at illness onset, gender, marital status, inpatient/outpatient status, family history, baseline YBOCS score, comorbidities, and remission.
RESULTS: Seventeen studies (pooled N = 1,265) fit the selection criteria and were used for the meta-analysis. The pooled sample had a mean follow-up duration 4.91 years and was predominantly male and outpatient and had onset of illness in the second decade, illness duration more than 10 years, and moderate-to-severe OCD. Pooled remission rate was 53% (95% CI, 42%-65%). Prospective studies showed higher pooled remission rate than retrospective studies (55% [95% CI, 45%-65%] vs 50% [95% CI, 27%-73%], P < .001). Indian studies showed higher pooled remission rate than others (71% [95% CI, 59%-83%] vs 48% [95% CI, 37%-59%], P < .001). Age at onset (t = -7.08, P = .019), illness duration (t = -8.13, P = .015), baseline YBOCS score (t = -6.81,P = .021), and male gender (t = -5.92, P = .027) had significant negative association with remission on meta-regression.
CONCLUSION: A high long-term remission rate found in this meta-analysis is contrary to generally held beliefs about poor outcome of individuals with OCD. Multicenter, prospective, long-term studies should systematically examine course and outcome in larger samples, emphasizing symptomatic and functional recovery. © Copyright 2014 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25295427     DOI: 10.4088/JCP.13r08849

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  11 in total

1.  Long-term Outcomes of Intensive Inpatient Care for Severe, Resistant Obsessive-Compulsive Disorder: Résultats à long terme de soins intensifs à des patients hospitalisés pour un trouble obsessionnel-compulsif grave et résistant.

Authors:  Srinivas Balachander; Aakash Bajaj; Nandita Hazari; Ajay Kumar; Nitin Anand; M Manjula; Paulomi M Sudhir; Anish V Cherian; Janardhanan C Narayanaswamy; T S Jaisoorya; Suresh Bada Math; Thennarasu Kandavel; Shyam Sundar Arumugham; Y C Janardhan Reddy
Journal:  Can J Psychiatry       Date:  2020-05-26       Impact factor: 4.356

2.  Neurocognitive Endophenotypes of OCD.

Authors:  Matilde M Vaghi
Journal:  Curr Top Behav Neurosci       Date:  2021

3.  Obsessive belief and emotional appraisal correlates of symptom dimensions and impairment in obsessive-compulsive disorder.

Authors:  Reema Sinha; Pooja Mahour; Eesha Sharma; Urvakhsh M Mehta; Manu Agarwal
Journal:  Indian J Psychiatry       Date:  2021-08-07       Impact factor: 1.759

Review 4.  Obsessive-compulsive disorder.

Authors:  Dan J Stein; Daniel L C Costa; Christine Lochner; Euripedes C Miguel; Y C Janardhan Reddy; Roseli G Shavitt; Odile A van den Heuvel; H Blair Simpson
Journal:  Nat Rev Dis Primers       Date:  2019-08-01       Impact factor: 52.329

5.  Task-based fMRI predicts response and remission to exposure therapy in obsessive-compulsive disorder.

Authors:  David Pagliaccio; Rachel Middleton; Dianne Hezel; Shari Steinman; Ivar Snorrason; Marina Gershkovich; Raphael Campeas; Anthony Pinto; Page Van Meter; H Blair Simpson; Rachel Marsh
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

6.  Duration of untreated illness of patients with obsessive-compulsive disorder in Japan.

Authors:  Yoshihiro Matsumoto; Takashi Nakamae; Yoshinari Abe; Anri Watanabe; Jin Narumoto
Journal:  Early Interv Psychiatry       Date:  2020-12-29       Impact factor: 2.721

7.  Cognitive remediation therapy (CRT) as a treatment enhancer of eating disorders and obsessive compulsive disorders: study protocol for a randomized controlled trial.

Authors:  Boris van Passel; Unna Danner; Alexandra Dingemans; Eric van Furth; Lot Sternheim; Annemarie van Elburg; Agnes van Minnen; Marcel van den Hout; Gert-Jan Hendriks; Daniëlle Cath
Journal:  BMC Psychiatry       Date:  2016-11-10       Impact factor: 3.630

8.  Clinical practice guidelines for Obsessive-Compulsive Disorder.

Authors:  Y C Janardhan Reddy; A Shyam Sundar; Janardhanan C Narayanaswamy; Suresh Bada Math
Journal:  Indian J Psychiatry       Date:  2017-01       Impact factor: 1.759

9.  From Treatment Response to Recovery: A Realistic Goal in OCD.

Authors:  Elisabetta Burchi; Eric Hollander; Stefano Pallanti
Journal:  Int J Neuropsychopharmacol       Date:  2018-11-01       Impact factor: 5.176

Review 10.  Trichotillomania is more related to Tourette disorder than to obsessive-compulsive disorder.

Authors:  Hugues Lamothe; Jean-Marc Baleyte; Luc Mallet; Antoine Pelissolo
Journal:  Braz J Psychiatry       Date:  2020 Jan-Feb       Impact factor: 2.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.